Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Hypogonadism 4Eunuchism 2Testicular Neoplasms 1Prostatic Neoplasms 1Prostate Cancer Recurrent 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia Type 1 1Klinefelter Syndrome 1Infertility 1Fatigue Syndrome, Chronic 1Carcinoma, Renal Cell 1

Interventions

pembrolizumab 155Gemcitabine 139Capecitabine 121Paclitaxel 118Fluorouracil 116Oxaliplatin 110Bevacizumab 104Nivolumab 97Leucovorin 97Docetaxel 92Cisplatin 89Irinotecan 87Carboplatin 84Radiosurgery 83Cyclophosphamide 70Cetuximab 70Magnetic Resonance Spectroscopy 68Trastuzumab 56Specimen Handling 56Biopsy 56Radiotherapy 55Ipilimumab 52Everolimus 48Pemetrexed 46Drug Therapy 45Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 43Doxorubicin 41Fulvestrant 38aldesleukin 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasm Metastasis × testosterone undecanoate × Clear all
NCT02966652 2019-11-26

Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism

Neurocrine UK Limited

Phase 1 Completed
25 enrolled

Eunuchism, Hypogonadism, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡